Oseni Bashiru S, Akomolafe Oluseun F
Department of Biomedical Sciences, College of Health Sciences, Ladoke Akintola University of Technology, P.M.B. - 4000, Ogbomosho, Oyo State, Nigeria.
Asian J Transfus Sci. 2011 Jan;5(1):46-8. doi: 10.4103/0973-6247.75998.
ABO incompatibility in maternal-fetal relationship has been shown to cause hemolytic disease of the newborn (HDNB); a survey which is not yet done in this locality.
Frequency of ABO blood group maternal-fetal incompatibility, maternal iso-agglutinins, and immune agglutinins quantitation was carried out in Osogbo, Osun State, South-West of Nigeria.
A total of 260 subjects comprising 130 postpartum mothers within the age range of 22-35 years having good obstetrics history and normal delivery, with their 130 neonate babies were used for the study.
ABO cell and serum groupings were carried out on the subjects using standard antisera and cells with appropriate controls. Direct Coomb's Test was carried out on neonate red cells. Antibody quantitation by double dilution on the maternal serum using red cells containing corresponding antigen to the antibody was determined. A titer, which is the reciprocal of the highest dilution showing agglutination by Indirect Coombs Test, was determined. Another batch of sera was pretreated with 2-mecarptoethanol before determining the titer.
The distribution study results obtained were compared in percentages, whereas the antibodies quantitation was expressed as titers using the mode of the titers for compariso-agglutininsn.
Thirty-eight percent (50) mothers were ABO incompatible with their babies, whereas 62% (80) mothers were compatible. The distribution of blood groups in the compatible population showed blood group O (45%); A (30%); B (20%); and AB (5%). Mothers O, A, and B carrying incompatible babies had a frequency of 24% each, whereas mothers AB had 28%. Serologist differences occur in maternal ABO antibodies of corresponding incompatible baby ABO antigens. A high incidence of ABO maternal-fetal incompatibility observed without detection of immune agglutinins is indicative of a rare incidence of HDNB due to ABO incompatibility in the population studied.
母婴关系中的ABO血型不相容已被证明会导致新生儿溶血病(HDNB);本地区尚未进行过此类调查。
在尼日利亚西南部奥孙州奥索博市,对ABO血型母婴不相容的频率、母亲同种凝集素和免疫凝集素进行定量分析。
本研究共纳入260名受试者,其中包括130名年龄在22 - 35岁之间、产科病史良好且顺产的产后母亲及其130名新生儿。
使用标准抗血清和细胞以及适当的对照,对受试者进行ABO血型细胞和血清分组。对新生儿红细胞进行直接抗人球蛋白试验。使用含有与抗体相应抗原的红细胞,通过双倍稀释法对母亲血清中的抗体进行定量分析。通过间接抗人球蛋白试验确定效价,效价为出现凝集的最高稀释倍数的倒数。在确定效价之前,另一批血清用2 - 巯基乙醇进行预处理。
所获得的分布研究结果以百分比进行比较,而抗体定量以效价表示,使用效价的众数进行比较。
38%(50名)母亲与她们的婴儿存在ABO血型不相容,而62%(80名)母亲与婴儿血型相容。相容人群中血型分布为:O型(45%);A型(30%);B型(20%);AB型(5%)。携带不相容婴儿的O型、A型和B型母亲的频率均为24%,而AB型母亲为28%。在母亲针对相应不相容婴儿ABO抗原的ABO抗体中存在血清学差异。在所研究的人群中,观察到ABO母婴血型不相容的发生率较高,但未检测到免疫凝集素,这表明由于ABO血型不相容导致的HDNB发生率较低。